Sanofi Launches Diabetes Drug Soliqua in India
April 30, 2024 12:38
Sanofi India has launched its diabetes drug Soliqua, a combination of insulin glargine and lixisenatide, offering a once-daily injectable treatment option for adults with type 2 diabetes.